Human placenta mesenchymal stem cell protection in ischemic stroke is angiotensin converting enzyme‐2 and masR receptor‐dependent

Thromboembolic stroke remains a major cause of neurological disability and death. Current stroke treatments (aspirin, tissue plasminogen activator) are significantly limited by timing and risks for hemorrhage which have driven researchers to explore other approaches. Stem cell‐based therapy appears...

Descripción completa

Detalles Bibliográficos
Autores principales: Barzegar, Mansoureh, Vital, Shantel, Stokes, Karen Y., Wang, Yuping, Yun, Jungmi Winny, White, Luke A., Chernyshev, Oleg, Kelley, Roger E., Alexander, Jonathan S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Regenerative Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881785/
https://www.ncbi.nlm.nih.gov/pubmed/34124808
http://dx.doi.org/10.1002/stem.3426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881785/
https://www.ncbi.nlm.nih.gov/pubmed/34124808
http://dx.doi.org/10.1002/stem.3426

Ejemplares similares